MEDICINA
Departament
Centro de Investigacion Biomedica en Red de Diabetes y Enfermedades Metabolicas Asociadas
Madrid, EspañaPublicacions en col·laboració amb investigadors/es de Centro de Investigacion Biomedica en Red de Diabetes y Enfermedades Metabolicas Asociadas (10)
2023
-
A second update on mapping the human genetic architecture of COVID-19
Nature
-
Physical activity patterns in type 1 diabetes in Spain: The SED1 study
BMC Sports Science, Medicine and Rehabilitation, Vol. 15, Núm. 1
2022
-
Novel genes and sex differences in COVID-19 severity
Human molecular genetics, Vol. 31, Núm. 22, pp. 3789-3806
2020
-
C3G contributes to platelet activation and aggregation by regulating major signaling pathways
Signal Transduction and Targeted Therapy, Vol. 5, Núm. 1
-
Corrigendum: Cost-Effective, Safe, and Personalized Cell Therapy for Critical Limb Ischemia in Type 2 Diabetes Mellitus (Frontiers in Immunology, (2019), 10, 10.3389/fimmu.2019.01151)
Frontiers in Immunology
2019
-
Cost-effective, safe, and personalized cell therapy for critical limb ischemia in type 2 diabetes mellitus
Frontiers in Immunology, Vol. 10, Núm. JUN
-
Survival analysis and sentinel lymph node status in thin cutaneous melanoma: A multicenter observational study
Cancer Medicine, Vol. 8, Núm. 9, pp. 4235-4244
2016
-
Urine metabolome profiling of immune-mediated inflammatory diseases
BMC Medicine, Vol. 14, Núm. 1
2008
-
Levels of SCS7/FA2H-mediated fatty acid 2-hydroxylation determine the sensitivity of cells to antitumor PM02734
Cancer Research, Vol. 68, Núm. 23, pp. 9779-9787